PMID- 16512610 OWN - NLM STAT- MEDLINE DCOM- 20060317 LR - 20061115 IS - 0208-0613 (Print) IS - 0208-0613 (Linking) IP - 1 DP - 2006 TI - [Her-2 gene dosage analysis in human breast cancer by PCR with internal standard]. PG - 34-8 AB - PCR assay with internal control was developed to quantify the her-2 gene dosage in human breast cancer tumor samples. Recombinant plasmid with a fragment of the her-2 gene containing the fragment of T7 phage DNA was designed especially to be used as an internal control in the PCR her-2 gene dosage assay. PCR conditions were optimized for the simultaneous usage of two templates--human genomic DNA and DNA of recombinant plasmid (internal control). The ability of the technology to discriminate a twofold increase of the her-2 gene dosage was demonstrated. Increased level of her-2 gene amplification was observed in 6 of 38 samples investigated. This new simple rapid assay can be an alternative to fluorescence in situ hybridization (FISH) and immunochemistry (ICH) tests for the detection of her-2 amplification in human tumors. This technique may be a useful tool for large randomized, prospective cooperative group trials and may support selection of optimal therapy for breast cancer patients in the future. FAU - Matsenko, N Iu AU - Matsenko NIu FAU - Kovalenko, S P AU - Kovalenko SP LA - rus PT - English Abstract PT - Journal Article PL - Russia (Federation) TA - Mol Gen Mikrobiol Virusol JT - Molekuliarnaia genetika, mikrobiologiia i virusologiia JID - 9315607 RN - 0 (DNA, Viral) SB - IM MH - Bacteriophage T7/genetics MH - Breast Neoplasms/diagnosis/*genetics MH - Carcinoma/diagnosis/*genetics MH - DNA, Viral MH - *Gene Dosage MH - Genes, erbB-2/*genetics MH - Humans MH - Plasmids MH - Polymerase Chain Reaction/*methods MH - Sensitivity and Specificity MH - Templates, Genetic EDAT- 2006/03/04 09:00 MHDA- 2006/03/18 09:00 CRDT- 2006/03/04 09:00 PHST- 2006/03/04 09:00 [pubmed] PHST- 2006/03/18 09:00 [medline] PHST- 2006/03/04 09:00 [entrez] PST - ppublish SO - Mol Gen Mikrobiol Virusol. 2006;(1):34-8.